January 1, 2010Open Access

Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

Key Points

Key points are not available for this paper at this time.

Abstract

Three years of treatment with the SQ-standardized grass allergy immunotherapy tablet resulted in consistent clinical improvement and accompanying immunologic changes that were sustained 1 year after treatment, which is indicative of disease modification and associated long-term benefits.

AIに質問

Bookmark

View Full Paper

Cite This Study

Durham et al. (Fri,) studied this question.

synapsesocial.com/papers/69da22690f32475823a3d0f8 https://doi.org/https://doi.org/10.1016/j.jaci.2009.10.035

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Immunotherapy with partially purified and standardized tree pollen extracts1988 · 136 citations
2The health economics of asthma and rhinitis. I. Assessing the economic impact2001 · 546 citations
3Nasal Symptoms Are Associated with School Performance in Adolescents2007 · 72 citations
4National prevalence of respiratory allergic disorders2004 · 82 citations
5Prevalence and rate of diagnosis of allergic rhinitis in Europe2004 · 1,027 citations

AIに質問

Bookmark

View Full Paper